Glucotrack (GCTK) Enterprise Value (2016 - 2020)
Historic Enterprise Value for Glucotrack (GCTK) over the last 7 years, with Q3 2020 value amounting to -$10.7 million.
- Glucotrack's Enterprise Value fell 77595.69% to -$10.7 million in Q3 2020 from the same period last year, while for Sep 2020 it was -$10.7 million, marking a year-over-year decrease of 77595.69%. This contributed to the annual value of -$419000.0 for FY2019, which is 33160.72% down from last year.
- As of Q3 2020, Glucotrack's Enterprise Value stood at -$10.7 million, which was down 77595.69% from -$11.5 million recorded in Q2 2020.
- Glucotrack's 5-year Enterprise Value high stood at $6.7 million for Q2 2018, and its period low was -$12.4 million during Q1 2020.
- Over the past 5 years, Glucotrack's median Enterprise Value value was -$97079.0 (recorded in 2018), while the average stood at $426157.3.
- Its Enterprise Value has fluctuated over the past 5 years, first soared by 396362.43% in 2017, then crashed by 4052852.56% in 2020.
- Quarter analysis of 5 years shows Glucotrack's Enterprise Value stood at $6.6 million in 2016, then rose by 1.45% to $6.7 million in 2017, then plummeted by 101.46% to -$97079.0 in 2018, then crashed by 331.61% to -$419000.0 in 2019, then crashed by 2455.29% to -$10.7 million in 2020.
- Its Enterprise Value stands at -$10.7 million for Q3 2020, versus -$11.5 million for Q2 2020 and -$12.4 million for Q1 2020.